CM Management’s Heron Therapeutics HRTX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$800K Buy
1,000,000
+250,000
+33% +$290K 0.67% 54
2025
Q4
$975K Hold
750,000
0.82% 43
2025
Q3
$945K Buy
750,000
+150,000
+25% +$238K 0.79% 49
2025
Q2
$1.24M Hold
600,000
1.13% 31
2025
Q1
$1.32M Sell
600,000
-100,000
-14% -$194K 1.33% 32
2024
Q4
$1.07M Buy
700,000
+200,000
+40% +$324K 0.96% 40
2024
Q3
$995K Buy
500,000
+200,000
+67% +$478K 0.79% 45
2024
Q2
$1.05M Hold
300,000
0.96% 39
2024
Q1
$831K Sell
300,000
-25,000
-8% -$62.8K 0.7% 47
2023
Q4
$553K Sell
325,000
-125,000
-28% -$138K 0.44% 53
2023
Q3
$464K Sell
450,000
-50,000
-10% -$71.2K 0.49% 49
2023
Q2
$580K Buy
500,000
+150,000
+43% +$268K 0.57% 50
2023
Q1
$529K Buy
350,000
+100,000
+40% +$250K 0.63% 44
2022
Q4
$625K Sell
250,000
-25,000
-9% -$80.5K 0.75% 46
2022
Q3
$1.16M Buy
275,000
+75,000
+38% +$293K 1.3% 28
2022
Q2
$558K Hold
200,000
0.59% 52
2022
Q1
$1.14M Buy
200,000
+150,000
+300% +$1.1M 0.96% 35
2021
Q4
$457K Sell
50,000
-10,000
-17% -$102K 0.35% 76
2021
Q3
$641K Buy
60,000
+10,000
+20% +$122K 0.48% 66
2021
Q2
$776K Hold
50,000
0.56% 63
2021
Q1
$811K Buy
50,000
+35,000
+233% +$624K 0.6% 65
2020
Q4
$317K Buy
+15,000
New +$261K 0.29% 70

Other funds holding HRTX